Cargando…
Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity
The obesity epidemic has contributed to an escalating prevalence of metabolic diseases in children. Overnutrition leads to increased tryptophan uptake and availability. An association between the induction of the tryptophan catabolic pathway via indoleamine 2,3-dioxygenase (IDO) activity and obesity...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781866/ https://www.ncbi.nlm.nih.gov/pubmed/35057467 http://dx.doi.org/10.3390/nu14020286 |
_version_ | 1784638183019905024 |
---|---|
author | Lischka, Julia Schanzer, Andrea Baumgartner, Margot de Gier, Charlotte Greber-Platzer, Susanne Zeyda, Maximilian |
author_facet | Lischka, Julia Schanzer, Andrea Baumgartner, Margot de Gier, Charlotte Greber-Platzer, Susanne Zeyda, Maximilian |
author_sort | Lischka, Julia |
collection | PubMed |
description | The obesity epidemic has contributed to an escalating prevalence of metabolic diseases in children. Overnutrition leads to increased tryptophan uptake and availability. An association between the induction of the tryptophan catabolic pathway via indoleamine 2,3-dioxygenase (IDO) activity and obesity-related inflammation has been observed. This study aimed to investigate the impact of pediatric obesity on tryptophan metabolism and the potential relationship with metabolic disease. In this prospective cohort study, plasma kynurenine, tryptophan, and serotonin levels were measured by ELISA, and IDO activity was estimated by calculating the kynurenine/tryptophan ratio in a clinically characterized population with severe obesity (BMI ≥ 97th percentile) aged 9 to 19 (n = 125). IDO activity and its product kynurenine correlated with BMI z-score and body fat mass, whereas concentrations of serotonin, the alternative tryptophan metabolite, negatively correlated with these measures of adiposity. Kynurenine and tryptophan, but not serotonin levels, were associated with disturbed glucose metabolism. Tryptophan concentrations negatively correlated with adiponectin and were significantly higher in prediabetes and metabolically unhealthy obesity. In conclusion, BMI and body fat mass were associated with increased tryptophan catabolism via the kynurenine pathway and decreased serotonin production in children and adolescents with severe obesity. The resulting elevated kynurenine levels may contribute to metabolic disease in obesity. |
format | Online Article Text |
id | pubmed-8781866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87818662022-01-22 Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity Lischka, Julia Schanzer, Andrea Baumgartner, Margot de Gier, Charlotte Greber-Platzer, Susanne Zeyda, Maximilian Nutrients Article The obesity epidemic has contributed to an escalating prevalence of metabolic diseases in children. Overnutrition leads to increased tryptophan uptake and availability. An association between the induction of the tryptophan catabolic pathway via indoleamine 2,3-dioxygenase (IDO) activity and obesity-related inflammation has been observed. This study aimed to investigate the impact of pediatric obesity on tryptophan metabolism and the potential relationship with metabolic disease. In this prospective cohort study, plasma kynurenine, tryptophan, and serotonin levels were measured by ELISA, and IDO activity was estimated by calculating the kynurenine/tryptophan ratio in a clinically characterized population with severe obesity (BMI ≥ 97th percentile) aged 9 to 19 (n = 125). IDO activity and its product kynurenine correlated with BMI z-score and body fat mass, whereas concentrations of serotonin, the alternative tryptophan metabolite, negatively correlated with these measures of adiposity. Kynurenine and tryptophan, but not serotonin levels, were associated with disturbed glucose metabolism. Tryptophan concentrations negatively correlated with adiponectin and were significantly higher in prediabetes and metabolically unhealthy obesity. In conclusion, BMI and body fat mass were associated with increased tryptophan catabolism via the kynurenine pathway and decreased serotonin production in children and adolescents with severe obesity. The resulting elevated kynurenine levels may contribute to metabolic disease in obesity. MDPI 2022-01-11 /pmc/articles/PMC8781866/ /pubmed/35057467 http://dx.doi.org/10.3390/nu14020286 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lischka, Julia Schanzer, Andrea Baumgartner, Margot de Gier, Charlotte Greber-Platzer, Susanne Zeyda, Maximilian Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity |
title | Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity |
title_full | Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity |
title_fullStr | Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity |
title_full_unstemmed | Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity |
title_short | Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity |
title_sort | tryptophan metabolism is associated with bmi and adipose tissue mass and linked to metabolic disease in pediatric obesity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781866/ https://www.ncbi.nlm.nih.gov/pubmed/35057467 http://dx.doi.org/10.3390/nu14020286 |
work_keys_str_mv | AT lischkajulia tryptophanmetabolismisassociatedwithbmiandadiposetissuemassandlinkedtometabolicdiseaseinpediatricobesity AT schanzerandrea tryptophanmetabolismisassociatedwithbmiandadiposetissuemassandlinkedtometabolicdiseaseinpediatricobesity AT baumgartnermargot tryptophanmetabolismisassociatedwithbmiandadiposetissuemassandlinkedtometabolicdiseaseinpediatricobesity AT degiercharlotte tryptophanmetabolismisassociatedwithbmiandadiposetissuemassandlinkedtometabolicdiseaseinpediatricobesity AT greberplatzersusanne tryptophanmetabolismisassociatedwithbmiandadiposetissuemassandlinkedtometabolicdiseaseinpediatricobesity AT zeydamaximilian tryptophanmetabolismisassociatedwithbmiandadiposetissuemassandlinkedtometabolicdiseaseinpediatricobesity |